Vaccination with Recombinant RNA Replicon Particles Protects Chickens from H5N1 Highly Pathogenic Avian Influenza Virus

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Halbherr, Stefan J ^a   Brostoff, Terza ^a,b   Tippenhauer, Merve ^a   Locher, Samira ^a   Berger Rentsch, Marianne ^a   Zimmer, Gert ^a  

^a INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; RNA VACCINE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CHICKEN; CONTROLLED STUDY; HELPER CELL; HUMORAL IMMUNITY; INFLUENZA A (H5N1); NONHUMAN; NUCLEOTIDE SEQUENCE; PROTECTION; REPLICON; RNA IMMUNIZATION; VESICULAR STOMATITIS VIRUS; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANIMALS; BLOTTING, WESTERN; CHICKENS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; REAL-TIME POLYMERASE CHAIN REACTION; REPLICON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; VACCINATION; VESICULOVIRUS; VIRION; VIRUS SHEDDING;

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; VESICULAR STOMATITIS VIRUS;

EID: 84878826668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066059     Document Type: Article

References (55)

1. Webster RG, Peiris M, Chen H, Guan Y, (2006) H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 12: 3-8.
2. Chen H, (2009) H5N1 avian influenza in China. Sci China C Life Sci 52: 419-427.
3. Klenk HD, Garten W, (1994) Host cell proteases controlling virus pathogenicity. Trends Microbiol 2: 39-43.
4. Veits J, Weber S, Stech O, Breithaupt A, Graber M, et al. (2012) Avian influenza virus hemagglutinins H2, H4, H8, and H14 support a highly pathogenic phenotype. Proc Natl Acad Sci U S A 109: 2579-2584.
5. Webster RG, Govorkova EA, (2006) H5N1 influenza-continuing evolution and spread. N Engl J Med 355: 2174-2177.
6. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD, (2004) Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A 101: 4620-4624.
7. Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y, (2008) Human infection with highly pathogenic H5N1 influenza virus. Lancet 371: 1464-1475.
8. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, et al. (2004) Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 101: 1356-1361.
9. Van Hoeven N, Pappas C, Belser JA, Maines TR, Zeng H, et al. (2009) Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci U S A 106: 3366-3371.
10. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, et al. (2012) Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486: 420-428.
11. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, et al. (2012) Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336: 1534-1541.
12. Russell CA, Fonville JM, Brown AE, Burke DF, Smith DL, et al. (2012) The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 336: 1541-1547.
13. Swayne DE, (2012) Impact of vaccines and vaccination on global control of avian influenza. Avian Dis 56: 818-828.
14. Poetri O, Bouma A, Claassen I, Koch G, Soejoedono R, et al. (2011) A single vaccination of commercial broilers does not reduce transmission of H5N1 highly pathogenic avian influenza. Vet Res 42: 74.
15. Isoda N, Sakoda Y, Kishida N, Soda K, Sakabe S, et al. (2008) Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Arch Virol 153: 1685-1692.
16. van der Goot JA, Koch G, de Jong MC, van Boven M, (2005) Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc Natl Acad Sci U S A 102: 18141-18146.
17. Poetri ON, Bouma A, Murtini S, Claassen I, Koch G, et al. (2009) An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens. Vaccine 27: 2864-2869.
18. Capua I, Cattoli G, Marangon S, (2004) DIVA-a vaccination strategy enabling the detection of field exposure to avian influenza. Dev Biol (Basel) 119: 229-233.
19. Capua I, Schmitz A, Jestin V, Koch G, Marangon S, (2009) Vaccination as a tool to combat introductions of notifiable avian influenza viruses in Europe, 2000 to 2006. Rev Sci Tech 28: 245-259.
20. Gambaryan AS, Lomakina NF, Boravleva EY, Kropotkina EA, Mashin VV, et al. (2012) Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine). Influenza Other Respi Viruses 6: 188-195.
21. Kalhoro NH, Veits J, Rautenschlein S, Zimmer G, (2009) A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1). Vaccine 27: 1174-1183.
22. Hanika A, Larisch B, Steinmann E, Schwegmann-Wessels C, Herrler G, et al. (2005) Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes. J Gen Virol 86: 1455-1465.
23. Manzoor R, Sakoda Y, Nomura N, Tsuda Y, Ozaki H, et al. (2009) PB2 protein of a highly pathogenic avian influenza virus strain A/chicken/Yamaguchi/7/2004 (H5N1) determines its replication potential in pigs. J Virol 83: 1572-1578.
24. Soda K, Sakoda Y, Isoda N, Kajihara M, Haraguchi Y, et al. (2008) Development of vaccine strains of H5 and H7 influenza viruses. Jpn J Vet Res 55: 93-98.
25. Nicolson C, Major D, Wood JM, Robertson JS, (2005) Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 23: 2943-2952.
26. Ocana-Macchi M, Bel M, Guzylack-Piriou L, Ruggli N, Liniger M, et al. (2009) Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells. J Virol 83: 12947-12955.
27. Brownie C, Statt J, Bauman P, Buczynski G, Skjolaas K, et al. (2011) Estimating viral titres in solutions with low viral loads. Biologicals 39: 224-230.
28. Fung KP, Wong TW, (1989) Estimation of quantal dose response of drugs by the Spearman-Karber method: a computer program written in BASIC. J Singapore Paediatr Soc 31: 129-132.
29. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR, (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289.
30. Stech J, Stech O, Herwig A, Altmeppen H, Hundt J, et al. (2008) Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification. Nucleic Acids Res 36: e139.
31. Hai R, Krammer F, Tan GS, Pica N, Eggink D, et al. (2012) Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J Virol 86: 5774-5781.
32. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR, (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77: 61-68.
33. Berger Rentsch M, Zimmer G, (2011) A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS One 6: e25858.
34. Sutter G, Ohlmann M, Erfle V, (1995) Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett 371: 9-12.
35. Kyhse-Andersen J, (1984) Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 10: 203-209.
36. Hofmann MA, Renzullo S, Baumer A, (2008) Phylogenetic characterization of H5N1 highly pathogenic avian influenza viruses isolated in Switzerland in 2006. Virus Genes 37: 407-413.
37. Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, et al. (2002) Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 40: 3256-3260.
38. Cattoli G, Milani A, Temperton N, Zecchin B, Buratin A, et al. (2011) Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus. J Virol 85: 8718-8724.
39. Han T, Marasco WA, (2011) Structural basis of influenza virus neutralization. Ann N Y Acad Sci 1217: 178-190.
40. Okuno Y, Isegawa Y, Sasao F, Ueda S, (1993) A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67: 2552-2558.
41. Smirnov YA, Lipatov AS, Gitelman AK, Okuno Y, Van Beek R, et al. (1999) An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus. Acta Virol 43: 237-244.
42. Sakabe S, Iwatsuki-Horimoto K, Horimoto T, Nidom CA, Le MQ, et al. (2010) A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. Antiviral Res 88: 249-255.
43. Wu WL, Chen Y, Wang P, Song W, Lau SY, et al. (2008) Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol 82: 1798-1807.
44. Cai Z, Ducatez MF, Yang J, Zhang T, Long LP, et al. (2012) Identifying antigenicity-associated sites in highly pathogenic H5N1 influenza virus hemagglutinin by using sparse learning. J Mol Biol 422: 145-155.
45. Kayali G, Kandeil A, El-Shesheny R, Kayed AS, Gomaa MR, et al. (2013) Do commercial avian influenza H5 vaccines induce cross-reactive antibodies against contemporary H5N1 viruses in Egypt? Poult Sci 92: 114-118.
46. Grund C, Abdelwhab el SM, Arafa AS, Ziller M, Hassan MK, et al. (2011) Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine 29: 5567-5573.
47. Schwartz JA, Buonocore L, Roberts A, Suguitan A Jr, Kobasa D, et al. (2007) Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection. Virology 366: 166-173.
48. WHO/OIE/FAO H5N1 evolution working group (2012) Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respi Viruses 6: 1-5.
49. Marangon S, Cecchinato M, Capua I, (2008) Use of vaccination in avian influenza control and eradication. Zoonoses Public Health 55: 65-72.
50. van der Goot JA, van Boven M, Stegeman A, van de Water SG, de Jong MC, et al. (2008) Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine. Virology 382: 91-97.
51. Eggert D, Swayne DE, (2010) Single vaccination provides limited protection to ducks and geese against H5N1 high pathogenicity avian influenza virus. Avian Dis 54: 1224-1229.
52. Lyles DS, (2000) Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol Mol Biol Rev 64: 709-724.
53. Hoffmann M, Wu YJ, Gerber M, Berger-Rentsch M, Heimrich B, et al. (2010) Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity. J Gen Virol 91: 2782-2793.
54. Kepp O, Senovilla L, Galluzzi L, Panaretakis T, Tesniere A, et al. (2009) Viral subversion of immunogenic cell death. Cell Cycle 8: 860-869.
55. Green DR, Ferguson T, Zitvogel L, Kroemer G, (2009) Immunogenic and tolerogenic cell death. Nat Rev Immunol 9: 353-363.